CEO at Terray Therapeutics
Jacob is a distinguished inventor at the intersection of nanotechnology and synthetic chemistry. Prior to joining Terray full-time, he ran an NIH-funded lab at City of Hope, where he was an associate professor. He has more than 40 publications, 20 patents and over 11 thousand citations associated with his work. He was named one of the “Rising Stars and Young Nanoarchitects in Materials Science” by the Royal Society of Chemistry and was nominated for the Kabiller Young Investigator Award in Nanoscience and Nanomedicine.
Jacob received his PhD in organometallic chemistry from CalTech where he studied with Nobel Laureate Bob Grubbs. Jacob completed his postdoctoral training at MIT and Rice University focusing on synthetic chemistry and nanotechnology, and received a BA in chemistry from Harvard University (magna cum laude).
Visit website: https://terraytx.com/#team
See also: Terray Therapeutics - Biotechnology company accelerating AI-driven drug discovery
Jacob Berlin News
Calico-Terray Therapeutics collaborate to discover and advance therapeutics for diseases of aging
Calico - 12-Oct-2022
Terray’s novel microarray technology, combines wet lab and computer-driven drug developmentRead more...